|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.78 USD | 0.00% |
|
+12.92% | -22.03% |
| 08-07 | Regenxbio Seen on Track for Duchenne Approval as Data Strengthens, RBC Says | MT |
| 08-06 | Sarepta Faces Competitive Pressures Despite Pipeline Updates, RBC Says | MT |
| Market Cap | 1.77B 1.53B 1.43B 1.31B 2.47B 169B 2.51B 16.8B 6.59B 84.55B 6.66B 6.51B 280B | P/E 2026 * |
5.55x | P/E 2027 * | 26x |
|---|---|---|---|---|---|
| Enterprise Value | 1.4B 1.21B 1.13B 1.04B 1.95B 133B 1.98B 13.25B 5.2B 66.7B 5.25B 5.14B 221B | EV / Sales 2026 * |
0.76x | EV / Sales 2027 * | 0.74x |
| Free-Float |
94.48% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Sarepta Therapeutics, Inc.
| 1 week | +12.92% | ||
| Current month | +12.92% | ||
| 1 month | -15.21% | ||
| 3 months | -19.33% | ||
| 6 months | -9.30% | ||
| Current year | -22.03% |
| 1 week | 14.75 |  | 17.26 |
| 1 month | 14.75 | | 20.88 |
| Current year | 14.68 | | 24.68 |
| 1 year | 14.68 | | 25.32 |
| 3 years | 10.42 | | 173.25 |
| 5 years | 10.42 | | 173.25 |
| 10 years | 10.42 | | 181.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Severino
CEO | Chief Executive Officer | 60 | 2026-07-27 |
Ryan Wong
DFI | Director of Finance/CFO | 47 | 2025-07-15 |
Ian Estepan
DFI | Director of Finance/CFO | 50 | 2020-12-13 |
| Director | Title | Age | Since |
|---|---|---|---|
M. Wilsey
CHM | Chairman | 73 | 2015-04-15 |
| Director/Board Member | 87 | 2010-05-31 | |
Richard Barry
BRD | Director/Board Member | 67 | 2015-06-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/28/26 | Free | Chief Executive Officer | 2,980,446 | 2.8230% | ||
| 3/11/26 | Tax | Chief Technology Officer | 948 | 0.0009% | ||
| 3/1/26 | Fiscal year | Chief Technology Officer | 20,735 | 0.0198% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +12.92% | -6.57% | -83.63% | 1.77B | |
| +0.35% | +4.01% | -6.90% | -28.31% | 2.55B | |
| +1.89% | +6.37% | -7.18% | -16.32% | 348M | |
| +2.29% | +2.29% | -46.86% | - | 55.71M | |
| Average | +1.13% | +6.26% | -16.88% | -42.75% | 1.18B | |
| Weighted average by Cap. | +0.35% | +7.48% | -7.27% | -48.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.84B 1.59B 1.49B 1.36B 2.56B 175B 2.6B 17.43B 6.84B 87.75B 6.91B 6.76B 290B | 1.39B 1.2B 1.12B 1.03B 1.94B 132B 1.97B 13.18B 5.17B 66.32B 5.22B 5.11B 219B |
| Net income | 360M 312M 291M 267M 502M 34.27B 510M 3.41B 1.34B 17.18B 1.35B 1.32B 56.79B | 60.69M 52.49M 49.02M 44.97M 84.58M 5.78B 85.93M 575M 226M 2.89B 228M 223M 9.57B |
| Net Debt | -374M -324M -302M -277M -521M -35.61B -530M -3.55B -1.39B -17.85B -1.41B -1.37B -59B | -741M -641M -598M -549M -1.03B -70.5B -1.05B -7.02B -2.76B -35.34B -2.78B -2.72B -117B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | US$16.78 | 0.00% | 3,064,146 |
| 26-08-06 | US$16.78 | +5.34% | 5,241,391 |
| 26-08-05 | US$15.93 | -2.81% | 3,109,305 |
| 26-08-04 | US$16.39 | +3.21% | 2,878,687 |
| 26-08-03 | US$15.88 | +6.86% | 3,799,658 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SRPT Stock
Select your edition
All financial news and data tailored to specific country editions
